MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 62 filers reported holding MIRATI THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,897,000 | -17.6% | 399,317 | +14.6% | 0.00% | – |
| Q3 2016 | $2,303,000 | +27.4% | 348,366 | +5.2% | 0.00% | – |
| Q2 2016 | $1,807,000 | -71.9% | 331,008 | +10.1% | 0.00% | -100.0% |
| Q1 2016 | $6,433,000 | -35.1% | 300,608 | -4.2% | 0.00% | -50.0% |
| Q4 2015 | $9,917,000 | -3.9% | 313,823 | +4.7% | 0.00% | -33.3% |
| Q3 2015 | $10,319,000 | +25.3% | 299,790 | +14.5% | 0.00% | +50.0% |
| Q2 2015 | $8,237,000 | +16.7% | 261,747 | +8.7% | 0.00% | 0.0% |
| Q1 2015 | $7,059,000 | +92.8% | 240,762 | +21.8% | 0.00% | +100.0% |
| Q4 2014 | $3,661,000 | +23.3% | 197,671 | +16.6% | 0.00% | 0.0% |
| Q3 2014 | $2,969,000 | -15.9% | 169,573 | -4.0% | 0.00% | 0.0% |
| Q2 2014 | $3,531,000 | – | 176,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |